Thailand UFG Fertility Center IVF Process and Suitable Population Analysis
===== Opening: Real Consultation Scenario =====
“Doctor, I am 43 years old, with AMH 0.8 ng/mL. I have had two failed IVF attempts in my home country. I heard that the PGT technology at Thailand UFG Fertility Center is good. Is my situation suitable for going there? What is the specific process?”
I. Thailand UFG Fertility Center IVF: Direct Answer
Thailand UFG Fertility Center (United Fertility Group) is an assisted reproductive institution located in Bangkok, characterized by fine embryo laboratory culture and PGT-A/PGT-M genetic screening. For families of advanced age, with repeated implantation failure, or carrying risks of single-gene genetic diseases, UFG provides a complete closed-loop process of “ovarian stimulation—egg retrieval—embryo culture—genetic testing—frozen embryo transfer.”
When is it suitable to choose UFG?
- Age ≥ 38 years, hoping to use PGT-A to screen for chromosomally normal embryos and reduce miscarriage rates.
- Repeated implantation failure (≥ 2 times), after excluding endometrial and immune factors, considering the possibility of embryonic chromosomal abnormalities.
- Known carrier of genetic diseases (such as thalassemia, spinal muscular atrophy, etc.), requiring PGT-M to avoid pathogenic genes.
- Moderately low ovarian reserve (AMH 0.5–1.2 ng/mL), but still with potential to retrieve eggs, needing an embryology laboratory experienced in vitrification and blastocyst culture.
When is it not suitable?
- Severely diminished ovarian function (AMH < 0.4 ng/mL, basal antral follicle count < 3), with slim hope of obtaining eggs through stimulation; should first consult about the egg donation pathway.
- Untreated uterine pathology (such as intrauterine adhesions, endometrial polyps, submucosal fibroids), requiring hysteroscopic treatment first.
- Uncontrolled systemic diseases (such as hypertension, diabetes, thyroid dysfunction), requiring stabilization before reassessment.
II. UFG IVF Actual Process and Timeline
The overall cycle typically requires 2 to 3 months, divided into three phases: domestic preparation, travel to Thailand for ovarian stimulation and egg retrieval, and the frozen embryo transfer cycle.
Phase 1: Domestic Preparation (approximately 4–6 weeks)
- Basic fertility assessment: AMH, FSH, LH, estradiol, antral follicle count (AFC).
- Semen analysis: Male routine semen analysis + morphology + DNA fragmentation index.
- Infectious disease screening: Hepatitis B, Hepatitis C, HIV, Syphilis, TORCH, etc. (valid for 6 months).
- Chromosomal karyotype analysis: Required for both partners (valid for life).
- Genetic counseling: If there is a family history of genetic disease, the proband's genetic report must be provided.
- Document preparation: Passport (valid for > 6 months), notarized and translated marriage certificate, visa (medical or tourist visa).
Phase 2: Travel to Thailand for Ovarian Stimulation and Egg Retrieval (approximately 14–16 days)
- Menstrual cycle day 2–3: Arrive in Bangkok, initial consultation with blood draw + ultrasound, develop an individualized ovarian stimulation protocol.
- Ovarian stimulation injections: Average 10–12 days, monitoring follicle development and hormone levels every 2–4 days.
- Trigger and egg retrieval: When follicles reach ≥ 18 mm, administer HCG or GnRH-a trigger, followed by egg retrieval under general anesthesia 36 hours later.
- Post-retrieval observation: Rest for 2–3 hours; return to accommodation if no discomfort.
Phase 3: Embryo Culture, PGT Testing, and Frozen Embryo Transfer (approximately 3–5 weeks)
- Fertilization and culture: Fertilization via ICSI, blastocyst culture until day 5–6.
- PGT biopsy: Trophectoderm cell biopsy, sent for PGT-A or PGT-M, report turnaround time approximately 10–14 days.
- Frozen embryo transfer: In the subsequent cycle (natural or artificial cycle), prepare the endometrium and transfer 1 or 2 transferable embryos.
- Luteal support and pregnancy test: Blood test for HCG 12–14 days after transfer to confirm.
III. Reproductive Doctor's Perspective: UFG's Technical Positioning and Selection Logic
From a clinical standpoint, the core advantages of Thailand UFG lie in the refined operational capability of the embryology laboratory and the mature process of PGT testing. For the following three scenarios, doctors typically recommend focused evaluation:
- Chromosomal screening for advanced age: For women ≥ 40 years, the embryonic aneuploidy rate can reach 60%–80%. PGT-A can significantly reduce recurrent miscarriages caused by chromosomal abnormalities.
- Genetic disease prevention: UFG collaborates with third-party genetic testing institutions, covering PGT-M testing for over 200 single-gene diseases, but family haplotype construction is required first.
- Repeated implantation failure: After excluding uterine and immune factors, embryonic chromosomal abnormalities are the main cause. PGT-A can improve the implantation rate per single transfer.
However, it must be pointed out: PGT cannot increase the number of eggs, nor can it improve the embryo formation rate. It is merely a screening tool, not a treatment. For patients with extremely low ovarian reserve, even with PGT, there may be no embryos to test, resulting in no benefit.
============================================================ Module D: Differences Across Age Groups ============================================================IV. Treatment Differences and Expectations Across Age Groups
| Age Group | Ovarian Reserve Characteristics | UFG Protocol Focus | Average Number of Eggs Retrieved (Reference) | PGT-A Transferable Embryo Rate |
|---|---|---|---|---|
| ≤ 35 years | AMH ≥ 2.0, AFC ≥ 10 | Standard antagonist protocol, focus on OHSS prevention | 10–16 | 50%–65% |
| 36–39 years | AMH 1.0–2.0, AFC 6–10 | Individualized stimulation, addition of growth hormone or LH | 6–10 | 35%–50% |
| 40–43 years | AMH 0.5–1.0, AFC 3–6 | Mild stimulation or modified protocol, embryo accumulation strategy | 3–6 | 15%–30% |
| ≥ 44 years | AMH < 0.5, AFC ≤ 3 | Full communication of expectations, consider egg donation pathway | 1–3 | < 10% |
※ The above data are industry experience references; individual variations are significant. Actual cycle results may vary.
============================================================ Module G: Most Easily Overlooked Details ============================================================V. Most Easily Overlooked Details
- PGT-M requires prior library construction: If performing single-gene disease screening, blood samples from the patient and family members must be provided first for haplotype construction, which takes 4–6 weeks. Coordination with the center should be done in advance.
- Check passport validity: Thai medical visas typically require a passport valid for more than 6 months, and the visa stay is generally no longer than 60 days. Allow room for visa extension.
- Diet and rest during ovarian stimulation: A high-protein diet supports follicle development, but over-supplementation may worsen bloating. It is recommended to consume 1.2–1.5 g/kg of protein daily and avoid strenuous exercise.
- Management of bloating after egg retrieval: Days 3–5 post-retrieval are the high-risk period for OHSS. Monitor urine output and abdominal circumference changes. UFG typically uses a GnRH-a trigger to reduce OHSS risk.
- Endometrial preparation for frozen embryo transfer: Artificial cycles require exogenous estrogen and progesterone. For patients with poor endometrial response, hysteroscopy or ERA testing (endometrial receptivity analysis) should be considered in advance.
VI. Cost Influencing Factors and Approximate Breakdown
The cost of IVF at Thailand UFG is not fixed and is mainly influenced by the following factors:
| Cost Item | Approximate Range (THB) | Description |
|---|---|---|
| Initial consultation tests + stimulation medications | 80,000 – 150,000 | Medication costs vary significantly depending on protocol and brand (imported vs. domestic) |
| Egg retrieval surgery + embryo culture | 120,000 – 180,000 | Includes ICSI, blastocyst culture, vitrification |
| PGT-A testing (per embryo) | 25,000 – 35,000 | Charged per embryo, includes biopsy and testing fees |
| PGT-M testing (per embryo) | 35,000 – 55,000 | Additional charges for probe design and family verification |
| Frozen embryo transfer cycle | 60,000 – 90,000 | Includes endometrial preparation, transfer procedure, luteal support |
| Third-party services (translation/accommodation/transportation) | 30,000 – 60,000 | Varies according to personal needs |
A complete “stimulation + PGT + frozen embryo transfer” cycle costs approximately 300,000 – 500,000 THB (equivalent to RMB 60,000 – 100,000), excluding airfare and living expenses. If multiple cycles are needed to accumulate embryos, the cost will increase accordingly.
============================================================ Module F: Differences Between Hospitals ============================================================VII. Differences Between UFG and Other Thai Fertility Centers
- Embryology laboratory: UFG uses time-lapse incubators, allowing continuous observation of embryo development dynamics and reducing disturbance from opening the incubator. Some centers still use traditional incubators relying on daily scheduled observations.
- PGT testing turnaround: UFG sends biopsy samples to a partner third-party genetic laboratory, with a report time of approximately 10–14 days. Some centers offer in-house rapid PGT, but the range of detectable loci may differ.
- Stimulation protocol preference: UFG doctors tend to favor mild stimulation strategies, especially for advanced age and low reserve patients, often using a modified protocol with clomiphene citrate + low-dose FSH to minimize follicle loss.
- Multidisciplinary collaboration: UFG has joint consultation sessions involving genetic counselors, embryologists, and reproductive doctors, providing a more systematic discussion for complex cases (e.g., repeated failure, genetic diseases).
Choosing a center essentially involves matching your own medical needs. If the primary goal is genetic disease screening, UFG's PGT-M process and genetic counseling capabilities are a plus. If the primary goal is improving pregnancy rates at an advanced age, equal attention should be paid to the stimulation protocol and laboratory survival rates.
============================================================ Closing: Risk Reminder ============================================================- Limitations of PGT testing: PGT-A can only screen for chromosomal aneuploidies and large structural abnormalities; it cannot detect microdeletions or single base mutations (requires PGT-M), nor does it guarantee a 100% miscarriage-free outcome after transfer.
- Embryo freezing risk: The survival rate for vitrification is approximately 95%–98%, with a very low probability of thawing failure or embryo damage.
- Medical visa and travel uncertainties: In cases of cycle cancellation, no eggs retrieved, or no embryos available for biopsy, additional time and funds should be reserved.
- Age is the biggest variable: Female age is the primary factor affecting egg quality and the rate of chromosomally normal embryos. No technology can reverse egg aging.
It is recommended to complete a full fertility assessment before making a decision and to have at least one in-depth discussion with a reproductive doctor and genetic counselor to clarify personal expectations and medical boundaries.
AMH FSH LH Antral Follicle Count Semen Analysis Chromosomal Testing Genetic Counseling Hysteroscopy Passport Validity Medical Visa Ovarian Stimulation Egg Retrieval Embryo Culture PGT-A PGT-M Frozen Embryo Transfer Luteal Support Time-lapse Incubator
===== Natural Coverage of Long-tail Keywords =====📌 Related Searches: When to do overseas IVF examinations · How long in advance to prepare for overseas IVF · Passport validity requirements for overseas IVF · What documents are needed for Thailand IVF registration · What to prepare for advanced age overseas IVF · Can I still do overseas IVF with low AMH · Male examination items for overseas IVF
